Cell Phenotype Evaluation at Various Sites After Skin Transplantation and FTY720 Plus Sirolimus Therapy

Transplantation Proceedings

Volumn 42, Issue 2, 2010, Pages 573-577

  Lopes, C T ^a   Rosin, F C P ^a   Cordeiro, J A ^b   Bueno, V ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Sao Jose do Rio Preto Medical School   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; FINGOLIMOD; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; AXILLARY LYMPH NODE; BLOOD; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LYMPHOCYTOPENIA; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN GRAFT; SKIN TRANSPLANTATION; SPLEEN; THYMOCYTE; THYMUS; TREATMENT DURATION;

ANIMALS; CELL COUNT; FLOW CYTOMETRY; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; PHENOTYPE; PROPYLENE GLYCOLS; SIROLIMUS; SKIN; SKIN TRANSPLANTATION; SPHINGOSINE; TRANSPLANTATION, HOMOLOGOUS;

EID: 77949471998     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.01.027     Document Type: Article

References (15)

1. Baratin M., Bonin K., and Daniel C. Peripheral priming of alloreactive T cells by the direct pathway of allorecognition. Eur J Immunol 34 (2004) 3305
2. 1 phase of the cycle. J Cell Physiol 154 (1993) 7
3. Mandala S., Hajdu R., Bergstrom J., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296 (2002) 346
4. Suzuki T., Jin M.B., Shimamura T., et al. A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single drug, induction and combination treatments. Transplant Int 17 (2004) 574
5. Lima R.S.M., Nogueira-Martins M.F., Silva Jr. H.T., et al. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination. Transplant Proc 36 (2004) 1015
6. Mayer K., Birnbaum F., Reinhard T., et al. FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations. Br J Ophthalmol 88 (2004) 915
7. Prememko-Lanier M., Moseley N.B., Pruett S.T., et al. Transient FTY720 treatment promotes immune-mediated clearance of a chronic viral infection. Nature 454 (2008) 894
8. + T-lymphocyte subpopulations expressing chemokine and adhesion receptors. Nephrol Dial Transplant 19 (2004) 702
9. Engelhardt E., Toksoy A., Goebeler M., et al. Chemokines IL-8, Groa, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 153 (1998) 1849
10. Woltman A.M., van der Kooij S.W., Coffer P.J., et al. Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression. Blood 101 (2003) 1439
11. Monti P., Mercalli A., Leone B.G., et al. Rapamycin impairs antigen uptake of human dendritic cells. Transplantation 75 (2003) 137
12. Lopes C.T., Gallo A.P., Franco M., et al. Skin allograft survival and analysis of renal and blood parameters after FTY720+FK506 treatment. Transplant Proc 40 (2008) 856
13. Yasuo Y., Kazutoshi O., Nobutomo M., et al. Tumor necrosis factor-[beta] is associated with thymic apoptosis during acute rejection. Transplantation 66 (1998) 894
14. Yagi H., Kamba R., Chiba K., et al. Immunosuppressant FTY720 inhibits thymocyte emigration. Eur J Immunol 30 (2000) 1435
15. + T cells in the periphery. Transplantation 77 (2004) 183